Reported Earlier, Bicara Therapeutics Prices Upsized Initial Public Offering Of 17.5M Common Shares At $18/Share
Portfolio Pulse from Benzinga Newsdesk
Bicara Therapeutics has priced its upsized IPO of 17.5 million common shares at $18 each. The shares will trade on the Nasdaq under the symbol 'BCAX' starting September 13, 2024, with the offering expected to close on September 16, 2024.
September 13, 2024 | 7:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bicara Therapeutics is launching an upsized IPO with shares priced at $18. Trading on Nasdaq starts September 13, 2024, under the symbol 'BCAX'.
The IPO pricing and commencement of trading on Nasdaq are significant events for Bicara Therapeutics, likely to generate investor interest and impact the stock price positively in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100